ClinicalTrials.Veeva

Menu

The Effect of Message Framing on Blood Donation-Study 2

G

Guangzhou Blood Center

Status

Completed

Conditions

Rh Negative Blood Donor

Treatments

Other: Loss-frame questionnaire
Other: Gain-frame questionnaire

Study type

Interventional

Funder types

Other

Identifiers

NCT03741387
Message Framing effect 2

Details and patient eligibility

About

Rh negative blood group is a rare blood group in China, as it only accounts for 0.3-0.4 percent of the Han population. Therefore, low inventory is often found in blood collection and supply agencies in many regions in China. In order to assess the effects of the gain-versus-loss framing message on blood donation among Rh negative donors, we designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the questions which survey the attitude of saving patients lives, and the other was to survey the attitude of preventing patients from death. The questionnaires were randomly sent to Rh negative blood donors.

Enrollment

795 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Rh negative blood donors who have donated blood between 2016 and 2018.

Exclusion criteria

  • People who are Rh negative blood type but never have donated blood.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

795 participants in 2 patient groups

Gain-frame questionnaire
Experimental group
Description:
Questionnaire included a picture of a patient lying in bed entitled "Will you save his life?" Donors in this group will answer the questions about attitude of saving patients' lives.
Treatment:
Other: Gain-frame questionnaire
Loss-frame questionnaire
Experimental group
Description:
Questionnaire included a picture of a patient lying in bed entitled "Will you prevent him from death?" Donors in this group will answer the questions about the attitude of preventing patients from death.
Treatment:
Other: Loss-frame questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems